Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer The authors present a score that ...
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I identify how the use of world models is ...
Despite decades of progress in pharmaceutical R&D, the earliest phase of drug discovery—where molecules are conceived and designed—remains costly, inefficient, and burdened by high failure rates. Most ...
OpenAI’s o3: AI Benchmark Discrepancy Reveals Gaps in Performance Claims Your email has been sent The FrontierMath benchmark from Epoch AI tests generative models on difficult math problems. Find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results